U.S. Anesthesia Partners Board Appoints Robert Coward CEO
U.S. Anesthesia Partners, Inc. (USAP) today appointed Robert Coward as its Chief Executive Officer. Mr. Coward comes to USAP with a strong background leading major healthcare organizations, including roles as Executive Vice Chairman of US Acute Care Solutions, President of the Physician Services Division at Envision Healthcare and President of Sheridan Healthcare, where he also served as Chief Development Officer. He most recently served as an Operating Partner at Welsh, Carson, Anderson, and Stowe with a focus on healthcare.
“I am honored to be given this opportunity to lead such a talented group of clinical and business leaders and an organization with USAP’s reputation,” said USAP CEO Robert Coward. “USAP has set the standard for anesthesia care in the United States, and I look forward to working with our entire team--including the surgeons, facilities, and health care systems we support--to deliver the highest quality care to patients. USAP’s partnership model is unique in the industry and drives the physician alignment and engagement that is critical to navigating the healthcare challenges we face,” Coward said.
About U.S. Anesthesia Partners
USAP is the leading single-specialty anesthesia practice, dedicated to providing high-quality anesthesia services to over 2.3 million patients across the nation annually. With over 4,500 clinicians and expertise in many anesthesia subspecialties, including pediatric, cardiac and OB anesthesia, USAP sets the standard for high quality patient care. Its data-driven quality metrics enable continuous innovation and improvements that are shared across USAP via a robust Clinical Quality Committee and quality framework. This helps facilitate the delivery of consistent, high quality services for patients, surgeons, facilities and payers. The company’s clinicians serve healthcare communities in Texas, Florida, Colorado, Arizona, Nevada, Washington, Oklahoma, Kansas, and Maryland.